| Objective:The clinical efficacy and safety of mild moxibustion combined with Bobath technique in the treatment of limb dysfunction in patients with poststroke shoulder-hand syndrome stage I were objectively confirmed by a randomized controlled clinical trial,to provide evidence-based medicine for the clinical application of mild moxibustion combined with Bobath technique.Methods:90 patients with stage I shoulder hand syndrome after stroke admitted to a third class hospital in Guangdong from January 2021 to December 2021 were randomly divided into three groups: group A(mild moxibustion combined with Bobath nursing group),group B(mild moxibustion group)and group C(Bobath nursing group),with 30 cases in each group.The patients were treated for 5 days a week for 3 weeks.The effects before and after treatment were compared by visual pain scale,swelling score,simplified Fugl Meyer upper limb motor function score and activity of daily living scale.Using statistical software package spss22.0 for data management and statistical analysis,P<0.05,indicating a statistical difference.Results:1.The age and other data of the three groups were comparable(P>0.05).Among the 90 patients with shoulder hand syndrome stage I after stroke,no mild moxibustion intolerance and other adverse events occurred,and the trial was completed.2.Upper limb motor function(1)After three weeks of treatment,the upper limb motor function scores of the three groups were significantly higher than those before treatment(P<0.05).(2)The comparison between groups showed that the improvement of upper limb motor function score in group B was better than that in group C,and the difference was statistically significant(P<0.05).The improvement of upper limb motor function score in group A was better than that in group B and group C,and the difference was statistically significant(P<0.05).3.Pain(1)After three weeks of treatment,the pain scores of the three groups were significantly lower than those before treatment(P<0.05).(2)The comparison between groups showed that the improvement of pain score in group B was better than that in group C,and the difference was statistically significant(P<0.05).The improvement of pain score in group A was better than that in group B and group C,and the difference was statistically significant(P<0.05).4.Swelling(1)After three weeks of treatment,the swelling scores of the three groups were significantly lower than those before treatment(P<0.05).(2)The comparison between groups showed that the improvement of swelling score in group B was better than that in group C,and the difference was statistically significant(P<0.05).The improvement of swelling score in group A was better than that in group B and group C,and the difference was statistically significant(P<0.05).5.Daily living ability(1)After three weeks of treatment,the scores of ADL in the three groups were significantly higher than those before treatment(P<0.05).(2)The comparison between groups showed that the improvement of ADL score in group B was better than that in group C,and the difference was statistically significant(P<0.05).The improvement of ADL score in group A was better than that in group B and group C,and the difference was statistically significant(P<0.05).6.Comparison of effective rates of three groups of patients after treatment There was significant difference in the total clinical effective rate among the three groups(P<0.05).The clinical effect of group A was better than that of group B and group C.Conclusion:1.Mild moxibustion and Bobath technology can significantly improve the shoulder pain,hand swelling and upper limb motor function of patients with stage I shoulder hand syndrome after stroke,and improve the ability of daily living.The clinical effect is remarkable.2.The clinical efficacy of mild moxibustion combined with Bobath technology in the treatment of stage I patients with post-stroke shoulder hand syndrome is significantly better than that of single mild moxibustion treatment or Bobath nursing scheme,which shows that the clinical efficacy of mild moxibustion combined with Bobath technology in the treatment of stage I patients with post-stroke shoulder hand syndrome is better. |